A notable augmentation in the expression of FTO was observed in individuals diagnosed with clinical stage 3 of colon cancer, as compared to those diagnosed with clinical stage 2 and individuals without cancer (Fig. 2A). Here, FTO is linked to malignant colon neoplasm.